1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Wake Network, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults PSIL428, Oyster mushroom - Anxiety and Depression | Phase 2 | Withdrawn | Wake Network, Inc. | 2022-09-15 | 2022-06-30 |
Anxiety Disorders (1) · Depression (1)
pleurotolysin B, oyster mushroom (1)
Jamaica (1)
Roger Gibson (1) · Sharon White (1)